SPDR® S&P Biotech ETF (XBI)

Delayed Data
As of Feb 23
 +1.37 / +1.50%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks to provide investment results that- before fees and expenses- correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index")- the fund employs a sampling strategy. It generally invests substantially all- but at least 80%- of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.

Novice Trade: SPDR S&P Biotech ETF
Feb 21 / TheStreet.com - Paid Partner Content


1 month-3.40% 3 years+9.31%
3 months+13.35% 5 years+24.41%
1 year+38.38% Since inception+15.78%
Data through 02/24/2018

Quote Details

Previous close$91.17
Open day’s range90.13 – 92.58
Net asset value (NAV)92.63 (02/23/2018)
Daily volume4,628,893
Average volume (3 months)4,604,903
Data as of 8:00pm ET, 02/23/2018

Peer Comparisonvs. Health ETFs

Performance 5-yr return+24.41%+17.28%
Expense Gross exp ratio0.35%1.31%
Risk 5 year sharpe ratio0.861.11
Net assets$4.9B$3.2B
Average market cap$4.0B$9.5B
Average P/E--22.6
Dividend / Share--0.34%


XLV Health Care Select Sector SPDR® Fund
RYH Guggenheim S&P 500® Equal Weight Health...
FHLC Fidelity® MSCI Health Care Index ETF


Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
BIVV Bioverativ Inc2.73%
JUNO Juno Therapeutics Inc2.00%
MDXG MiMedx Group Inc1.94%
ARRY Array Biopharma Inc1.80%
FOLD Amicus Therapeutics Inc1.67%
SRPT Sarepta Therapeutics Inc1.65%
AVXS AveXis Inc1.64%
BLUE bluebird bio Inc1.63%
LOXO Loxo Oncology Inc1.63%
IMMU Immunomedics Inc1.61%